Article
BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA - 1 Aug 2005
Palomba Stefano, Orio Francesco, Russo Tiziana, Falbo Angela, Tolino Achille, Manguso Francesco, Nunziata Vincenzo, Mastrantonio Pasquale, Lombardi Gaetano, Zullo Fulvio
Abstract excerpt
Vitamin D receptor (VDR) gene polymorphisms could be considered one of the factors influencing the efficacy of the anti-osteoporotic treatments. In this multicenter, prospective, randomized and controlled trial we evaluated whether BsmI vitamin D receptor (VDR) genotypes influence the efficacy of antiresorptive treatment regimes (administered alone or in combination) in postmenopausal osteoporotic women. Using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
